Who we are
Abiel is a ground breaking biotech Company founded as a spin-off of the National Council of Research (C.N.R.) and the University of Palermo and is composed by a multidisciplinary team of qualified scientists and professionals with expertise in enzymology, biochemistry, cell biology and biomarine sciences.
Abiel strives in developing high quality lytic enzymes to help advances in cell isolation for regenerative medicine and cell therapy applications.
What we do
Abiel is a biotechnology company committed to R&D, production and marketing of innovative high quality lytic enzymes for tissue dissociation in cell therapy and regenerative medicine applications.
Our tissue dissociation enzymes, synthesized by DNA recombinant technology, ensure high stability, batch-to-batch reproducibility and purity.
Abiel’s recombinant collagenases represent a step forward towards the optimization and standardization of cell isolation protocols, a major challenge in the future of regenerative medicine and cell therapy.
The Company’s sustainable growth is focused on identifying new proteolytic enzymes from biomarine sources for extractive processes at low temperature. This strategic commitment is closely linked to the scientific relationship with IAMC- CNR (Institute for Coastal Marine Environment of the National Research Council) of Capo Granitola (Campobello di Mazara), where part of Abiel’s research is located.